AGM/EGMApr 30, 2026, 04:30 PM
PRAX to Hold 2026 Annual Meeting; Elect Directors, Ratify Auditor
AI Summary
Praxis Precision Medicines, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 10, 2026. Key proposals include the election of three Class III directors, ratification of Ernst & Young LLP as the independent registered public accounting firm, and an advisory vote on executive compensation. The CEO highlighted meaningful progress in 2025 and a robust pipeline with transformative milestones for 2026, while also noting recent board and executive appointments.
Key Highlights
- 2026 Annual Meeting of Stockholders to be held virtually on June 10, 2026, at 9:00 a.m. ET.
- Stockholders to elect Gregory Norden, Marcio Souza, and William Young as Class III directors.
- Stockholders to ratify Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
- Advisory (non-binding) vote on compensation of named executive officers.
- Record date for voting is April 15, 2026.
- 27,872,305 shares of common stock outstanding on record date.
- CEO noted "meaningful progress" in 2025 and a "robust pipeline" for 2026.
- Stuart Arbuckle and Jeffrey Kindler joined board; Megan Sniecinski appointed COO in Jan 2026.
Price Impact
More from PRAX